Advertisement
Screener

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Deferred State and Local Income Tax Expense (Benefit)

INTEGRA LIFESCIENCES HOLDINGS CORP Deferred State and Local Income Tax Expense (Benefit)

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Deferred State and Local Income Tax Expense (Benefit) of -$6.87 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-26

  • INTEGRA LIFESCIENCES HOLDINGS CORP deferred state and local income tax expense (benefit) for fiscal 2025 was -$6.87M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP deferred state and local income tax expense (benefit) for fiscal 2024 was -$4.09M, a 4501.08% decline from fiscal 2023.
  • INTEGRA LIFESCIENCES HOLDINGS CORP deferred state and local income tax expense (benefit) for fiscal 2023 was $93.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP deferred state and local income tax expense (benefit) for fiscal 2022 was -$2.32M.
Period endDeferred State and Local Income Tax Expense (Benefit) 12 monthDeferred State and Local Income Tax Expense (Benefit) 12 month as first filed
2025-12-31-$6.87M
10-K · filed 2026-02-26
2024-12-31-$4.09M
10-K · filed 2026-02-26
2023-12-31$93.00K
10-K · filed 2026-02-26
2022-12-31-$2.32M
10-K · filed 2025-02-25
2021-12-31-$3.69M
10-K · filed 2024-02-28
2020-12-31-$1.76M
10-K · filed 2023-02-22
2019-12-31-$666.00K
10-K · filed 2022-02-24
2018-12-31-$3.05M
10-K · filed 2021-02-23
2017-12-31-$758.00K
10-K · filed 2020-02-21
2016-12-31-$1.75M
10-K · filed 2019-02-26
2015-12-31-$394.00K
10-K · filed 2018-03-01
2014-12-31$695.00K
10-K · filed 2017-02-23
$953.00K
10-K · filed 2015-02-27
2013-12-31-$1.14M
10-K · filed 2016-02-26
-$596.00K
10-K · filed 2014-02-27
2012-12-31$497.00K
10-K · filed 2015-02-27
2011-12-31$2.24M
8-K · filed 2014-06-20
2010-12-31$835.00K
10-K · filed 2013-02-26
2009-12-31-$672.00K
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92